Clinical Oncology
Volume 16, Issue 8 , Pages 530-535 , December 2004

Quality of life after non-surgical treatment of anal carcinoma: a case control study of long-term survivors

  • C.R. Jephcott

      Affiliations

    • Department of Radiation Oncology, British Columbia Cancer Agency, Vancouver, Canada
    • Department of Oncology, Churchill Hospital, Oxford, UK
    • Corresponding Author InformationAuthor for correspondence: Dr C.R. Jephcott, Department of Oncology, Churchill Hospital, Old Road, Headington, Oxford OX3 7LJ, UK. Tel: +44-1865-741841; Fax: +44-1865-225660.
    • ,
  • C. Paltiel

      Affiliations

    • Population and Preventive Oncology, British Columbia Cancer Agency, Vancouver, Canada
    • ,
  • J. Hay

      Affiliations

    • Department of Radiation Oncology, British Columbia Cancer Agency, Vancouver, Canada

Received 4 December 2003 ,Revised 12 May 2004 ,Accepted 18 May 2004.

References 

  1. Nigro ND, Vaitkevicius VK, Considine B. Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum. 1974;17:354–356
  2. Cummings BJ. Current management of epidermoid carcinoma of the anal canal. Gastroenterol Clin North Am. 1987;16:125–142
  3. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research. Lancet. 1996;348:1049–1054
  4. Slevin MLPPN, Ryan CM, Meadows HM, et al. Chemotherapy for anal cancer improves quality of life compared to radiotherapy alone [abstract]. American Society of Clinical Oncology Annual Meeting, 2002.
  5. Bartelink H, Roelofsen F, Eschwege F, et al.  Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol. 1997;15:2040–2049
  6. Aaronson NK, Ahmedzai S, Bergman B, et al.  The European Organisation for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–376
  7. Sprangers MAG, te Velde A, Aaronson NK. The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38). Eur J Cancer. 1999;35:238–247
  8. Allal AS, Sprangers MA, Laurencet F, et al.  Assessment of long-term quality of life in patients with anal carcinomas treated by radiotherapy with or without chemotherapy. Br J Cancer. 1999;80:1588–1594
  9. Fayers PM, Aaronson NK, Bjordal K, et al.  on behalf of the EORTC QoL group   The EORTC QLQ-C30 scoring manual. 3rd edn. Brussels: European Organisation for Research and Treatment of Cancer; 2001;
  10. Osoba D, Rodrigues G, Myles J, et al.  Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998;16:139–144
  11. American Society of Clinical Oncology. Mission Statement. http://www.asco.org/ac 2003; Date accessed: 20 October 2003
  12. Bye A, Tropé C, Loge JH, et al.  Health related quality of life and occurrence of Intestinal side effects after pelvic radiotherapy. Evaluation of long-term side effects of diagnosis and treatment. Acta Oncol. 2000;39:173–180
  13. Myerson RJ, Shapiro SJ, Lacey D, et al.  Carcinoma of the anal canal. Am J Clin Oncol. 1995;18:32–39
  14. John M, Flam M, Palma N. Ten year results of chemoradiation for anal cancer; focus on late morbidity. Int J Radiat Oncol Biol Phys. 1996;34:65–69
  15. Vordermark D, Sailer M, Flentfe M, et al.  Curative intent radiation therapy in anal carcinoma: quality of life and sphincer function. Radiother Oncol. 1999;52:239–243
  16. Klee M, Grenvold M, Machin D. Quality of life in Danish women: population-based norms for the EORTC QLQ-C30. Qual Life Res. 1997;6:27–34
  17. Hjermstad MJ, Fayers PM, Bjordal K, et al.  Health related quality of life in the general Norwegian population assessed by the European Organisation for Research and the Treatment of Cancer Core Quality of Life Questionnaire: The QLQ-C30 (+3). J Clin Oncol. 1998;16:1188–1196
  18. Schwartz R, Hinz A. Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer. 2001;37:1345–1351
  19. Fayers PM. Interpreting quality of life data: population-based reference data for the EORTC QLQ-C30. Eur J Cancer. 2001;377:1331–1334

PII: S0936-6555(04)00180-3

doi: 10.1016/j.clon.2004.05.007

Clinical Oncology
Volume 16, Issue 8 , Pages 530-535 , December 2004

Article Tools